Elizabeth A. David, MD, David T

Slides:

Advertisements

Similar presentations

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Advertisements

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Thomas J. Birdas, MD, Richard P. M

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival Elizabeth A. David, MD, Robert J. Canter,

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Chun Chieh Lin, PhD, MBA, Matthew P

Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non- Small Cell Lung Cancer Ken Kodama, MD, Masahiko Higashiyama, MD, Jiro.

Joshua E. Rosen, BASc, Hari B

Ravi Rajaram, MD, MSc, Jennifer L

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Castigliano M. Bhamidipati, DO, MS, George J

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Osteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival Yue Li, MD, Bing-sheng Sun, MD, PhD, Baoxiang Pei, MD, Chen-guang Li,

Surgical Treatment of Metachronous Second Primary Lung Cancer

Andrea S. Wolf, MD, MPH, Scott J

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Use of Amiodarone After Major Lung Resection

Increasing Rates of No Treatment in Advanced-Stage Non–Small Cell Lung Cancer Patients: A Propensity-Matched Analysis Elizabeth A. David, MD, Megan E.

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Video-Assisted Thoracoscopic Surgery is More Favorable Than Thoracotomy for Resection of Clinical Stage I Non-Small Cell Lung Cancer Bryan A. Whitson,

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

William M. Whited, MD, Paul Henley, BS, Erin M

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Stephen R. Broderick, MD, MPHS, Aalok P. Patel, BS, BA, Traves D

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Luis F. Tapias, MD, Douglas J. Mathisen, MD, Cameron D

Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer Hyun Jin Cho, MD, Sung Ryong Kim, MD, Hyeong Ryul Kim, MD,

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,

Mert Saynak, MD, Jessica Hubbs, MS, Jiho Nam, MD, Lawrence B

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

Presentation transcript:

Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer? Elizabeth A. David, MD, David T. Cooke, MD, Yingjia Chen, MPH, Kieranjeet Nijar, BS, MS, Robert J. Canter, MD, MAS, Rosemary D. Cress, DrPH The Annals of Thoracic Surgery Volume 103, Issue 1, Pages 226-235 (January 2017) DOI: 10.1016/j.athoracsur.2016.05.018 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Distribution of number of lymph nodes sampled. The Annals of Thoracic Surgery 2017 103, 226-235DOI: (10.1016/j.athoracsur.2016.05.018) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Number of lymph nodes sampled by type of resection: sublobar resection (solid bars), lobectomy (shaded bars), and pneumonectomy (open bars). The Annals of Thoracic Surgery 2017 103, 226-235DOI: (10.1016/j.athoracsur.2016.05.018) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Cause-specific survival Kaplan-Meier curves (log rank test, p < 0.0001) for (A) entire cohort, (B) stage I, (C) stage II, and (D) stage III. Number of lymph nodes removed: 0 (blue lines); 1 to 3 (red lines); 4 to 10 (green lines); and 10 or more (yellow lines). The Annals of Thoracic Surgery 2017 103, 226-235DOI: (10.1016/j.athoracsur.2016.05.018) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Overall survival Kaplan-Meier curves (log rank test, p < 0.0001) for (A) entire cohort, (B) stage I, (C) stage II, and (D) stage III. Number of lymph nodes removed: 0 (blue lines); 1 to 3 (red lines); 4 to 10 (green lines); and 10 or more (yellow lines). The Annals of Thoracic Surgery 2017 103, 226-235DOI: (10.1016/j.athoracsur.2016.05.018) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions